Manzarbeitia-Arroba, B.; Hodolic, M.; Pichler, R.; Osipova, O.; Soriano-Castrejón, Á.M.; García-Vicente, A.M.
18F-Fluoroethyl-L Tyrosine Positron Emission Tomography Radiomics in the Differentiation of Treatment-Related Changes from Disease Progression in Patients with Glioblastoma. Cancers 2024, 16, 195.
https://doi.org/10.3390/cancers16010195
AMA Style
Manzarbeitia-Arroba B, Hodolic M, Pichler R, Osipova O, Soriano-Castrejón ÁM, García-Vicente AM.
18F-Fluoroethyl-L Tyrosine Positron Emission Tomography Radiomics in the Differentiation of Treatment-Related Changes from Disease Progression in Patients with Glioblastoma. Cancers. 2024; 16(1):195.
https://doi.org/10.3390/cancers16010195
Chicago/Turabian Style
Manzarbeitia-Arroba, Begoña, Marina Hodolic, Robert Pichler, Olga Osipova, Ángel Maria Soriano-Castrejón, and Ana María García-Vicente.
2024. "18F-Fluoroethyl-L Tyrosine Positron Emission Tomography Radiomics in the Differentiation of Treatment-Related Changes from Disease Progression in Patients with Glioblastoma" Cancers 16, no. 1: 195.
https://doi.org/10.3390/cancers16010195
APA Style
Manzarbeitia-Arroba, B., Hodolic, M., Pichler, R., Osipova, O., Soriano-Castrejón, Á. M., & García-Vicente, A. M.
(2024). 18F-Fluoroethyl-L Tyrosine Positron Emission Tomography Radiomics in the Differentiation of Treatment-Related Changes from Disease Progression in Patients with Glioblastoma. Cancers, 16(1), 195.
https://doi.org/10.3390/cancers16010195
